 Eidos Therapeutics Inc NASDAQ:EIDX Investment analysts at SVB Leerink decreased their FY2021 earnings per share estimates for shares of Eidos Therapeutics in a research report issued on Wednesday, April 22nd. SVB Leerink analyst M. Foroohar now forecasts that the company will post earnings per share of 2.17 for the year, down from their previous ... 